Efficacy of ghrelin in cancer cachexia: Clinical trials and a novel treatment by rikkunshito

Critical Reviews in Oncogenesis

Volumn 17, Issue 3, 2012, Pages 277-284

  Fujitsuka, Naoki ^a,b   Asakawa, Akihiro ^a   Amitani, Haruka ^a   Hattori, Tomohisa ^b   Inui, Akio ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Tsumura Research Laboratories   (Japan)

Author keywords

Cachexia; Cancer; Ghrelin; GHS R; Rikkunshito

Indexed keywords

ANAMORELIN; APPETITE STIMULANT; BIM 28131; CISPLATIN; GHRELIN; GHRELIN RECEPTOR; GHRELIN RECEPTOR AGONIST; HORMONE RECEPTOR STIMULATING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; RIKKUNSHITO; SEROTONIN; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADVANCED CANCER; ARTICLE; CACHEXIA; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENERGY BALANCE; ENERGY EXPENDITURE; FOOD INTAKE; GASTROINTESTINAL MOTILITY DISORDER; HORMONE RELEASE; HUMAN; HUNGER; JAPANESE; LEAN BODY WEIGHT; MORBIDITY; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEROTONIN RELEASE; SIDE EFFECT; SIGNAL TRANSDUCTION; STOMACH FUNCTION; TRADITIONAL MEDICINE; WEIGHT GAIN;

CACHEXIA; CLINICAL TRIALS AS TOPIC; DRUGS, CHINESE HERBAL; GHRELIN; HUMANS; NEOPLASMS;

EID: 84863820506     PISSN: 08939675     EISSN: 21626448     Source Type: Journal    
DOI: 10.1615/CritRevOncog.v17.i3.50     Document Type: Article

References (50)

1. Tisdale MJ. Biology of cachexia. J Natl Cancer Inst. 1997 Dec 3;89(23):1763-73.
2. Mantovani G, Maccio A, Massa E, Madeddu C. Managing cancer-related anorexia/cachexia. Drugs. 2001;61(4):499-514.
3. Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin. 2002 Mar-Apr 52;(2):72-91.
4. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding. Nature. 2001 Jan 11;409(6817):194-8.
5. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA, Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology. 2001 Feb 120;(2):337-45.
6. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone- releasing acylated peptide from stomach. Nature. 1999 Dec 9;402(6762):656-60.
7. Fujino K, Inui A, Asakawa A, Kihara N, Fujimura M, Fujimiya M. Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol. 2003 Jul 1;550(Pt 1):227-40.
8. Granado M, Priego T, Martin AI, Villanua MA, Lopez-Calderon A. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab. 2005 Mar 288;(3):E486-E492.
9. Takeda H, Sadakane C, Hattori T, Katsurada T, Ohkawara T, Nagai K, Asaka M. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology. 2008 Jun 134;(7):2004-13.
10. Fujitsuka N, Asakawa A, Hayashi M, Sameshima M, Amitani H, Kojima S, Fujimiya M, Inui A. Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin. Biol Psychiatry. 2009 May 1;65(9):748-59.
11. Fujitsuka N, Asakawa A, Uezono Y, Minami K, Yamaguchi T, Niijima A, Yada T, Maejima Y, Sedbazar U, Sakai T, Hattori T, Kase Y, Inui A. Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival. Transl Psychiatry. 2011;1:e23.
12. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M. The tissue distribu- tion of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab. 2002 Jun 87;(6):2988.
13. Yang J, Brown MS, Liang G, Grishin NV, Gold-stein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell. 2008 Feb 8;132(3):387-96.
14. Akamizu T, Takaya K, Irako T, Hosoda H, Teramukai S, Matsuyama A, Tada H, Miura K, Shimizu A, Fukushima M, Yokode M, Tanaka K, Kangawa K. Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur J Endocrinol. 2004 Apr 150;(4):447-55.
15. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev. 2005 Apr 85;(2):495-522.
16. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K, Matsukura S. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab. 2002 Jan 87;(1):240-44.
17. Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams JR, Frazier EG, Shen Z, Marsh DJ, Feighner SD, Guan XM, Ye Z, Nargund RP, Smith RG, Van der Ploeg LH, Howard AD, MacNeil DJ, Qian S. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology. 2004 Jun 145;(6):2607-12.
18. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000 Oct 19 407;(6806):908-13.
19. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001 Dec 86;(12):5992.
20. Shimizu Y, Nagaya N, Isobe T, Imazu M, Okumura H, Hosoda H, Kojima M, Kangawa K, Kohno N. Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res. 2003 Feb 9;(2):774-8.
21. Garcia JM, Garcia-Touza M, Hijazi RA, Taffet G, Epner D, Mann D, Smith RG, Cunningham GR, Marcelli M. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab. 2005 May 90;(5):2920-6.
22. Flier JS. Clinical review 94: What's in a name? In search of leptin's physiologic role. J Clin Endocrinol Metab. 1998 May 83;(5):1407-13.
23. Schwartz MW, Dallman MF, Woods SC. Hypo-thalamic response to starvation: implications for the study of wasting disorders. Am J Physiol. 1995 Nov 269;(5 Pt 2):R949-R957.
24. Schwartz MW, Seeley RJ. Seminars in medicine of the Beth Israel Deaconess Medical Center. Neuro- endocrine responses to starvation and weight loss. N Engl J Med. 1997 Jun 19 336;(25):1802-11.
25. Perboni S, Inui A. Anorexia in cancer: role of feeding-regulatory peptides. Philos Trans R Soc Lond B Biol Sci. 2006 Jul 29;361(1471):1281-9.
26. Plata-Salaman CR. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition. 2000 Oct 16;(10):1009-12.
27. Shintani F, Kanba S, Nakaki T, Nibuya M, Kinoshita N, Suzuki E, Yagi G, Kato R, Asai M. Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J Neurosci. 1993 Aug 13;(8):3574-81.
28. Laviano A, Gleason JR, Meguid MM, Yang ZJ, Cangiano C, Rossi Fanelli F. Effects of intra-VMN mianserin and IL-1ra on meal number in anorec- tic tumor-bearing rats. J Investig Med. 2000 Jan 48;(1):40-8.
29. Wang W, Danielsson A, Svanberg E, Lundholm K. Lack of effects by tricyclic antidepressant and sero- tonin inhibitors on anorexia in MCG 101 tumor- bearing mice with eicosanoid-related cachexia. Nutrition. 2003 Jan 19;(1):47-53.
30. Makarenko IG, Meguid MM, Gatto L, Goncalves CG, Ramos EJ, Chen C, Chen C, Ugrumov MV. Hypothalamic 5-HT1B-receptor changes in ano- rectic tumor bearing rats. Neurosci Lett. 2005 Mar 11 376;(2):71-5.
31. Makarenko IG, Meguid MM, Gatto L, Chen C, Ugrumov MV. Decreased NPY innervation of the hypothalamic nuclei in rats with cancer anorexia. Brain Res. 2003 Jan 24 961;(1):100-8.
32. Hanada T, Toshinai K, Kajimura N, Nara-Ashizawa N, Tsukada T, Hayashi Y, Osuye K, Kangawa K, Matsukura S, Nakazato M. Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells. Biochem Biophys Res Commun. 2003 Feb 7 301;(2):275-9.
33. Wang W, Andersson M, Iresjo BM, Lonnroth C, Lundholm K. Effects of ghrelin on anorexia in tumor-bearing mice with eicosanoid-related cachexia. Int J Oncol. 2006 Jun 28;(6):1393-400.
34. DeBoer MD, Zhu XX, Levasseur P, Meguid MM, Suzuki S, Inui A, Taylor JE, Halem HA, Dong JZ, Datta R, Culler MD, Marks DL. Ghrelin treat- ment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology. 2007 Jun 148;(6):3004-12.
35. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW Jr, Taub DD. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest. 2004 Jul 114;(1):57-66.
36. Neary NM, Small CJ, Wren AM, Lee JL, Druce MR, Palmieri C, Frost GS, Ghatei MA, Coombes RC, Bloom SR. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, ran- domized, placebo-controlled trial. J Clin Endocrinol Metab. 2004 Jun 89;(6):2832-6.
37. Strasser F, Lutz TA, Maeder MT, Thuerlimann B, Bueche D, Tschop M, Kaufmann K, Holst B, Brändle M, von Moos R, Demmer R, Cerny T. Safety, tolerability and pharmacokinetics of intra- venous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. Br J Cancer. 2008 Jan 29;98(2):300-8.
38. Garcia JM, Boccia RV, Graham C, Kumor K, Polvino W. A Phase II, randomized, placebo-controlled, double blind study of the efficacy and safety of RC-1291 for the treatment of cancer-cachexia. J Clin Oncol. ASCO Annual Meeting Proceedings Part I. Vol. 25, No. 18S (June 20 Supplement), 2007: 9133.
39. Murata M, Okimura Y, Iida K, Matsumoto M, Sowa H, Kaji H, Kojima M, Kangawa K, Chihara K. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J Biol Chem. 2002 Feb 15;277(7):5667-74.
40. Ghe C, Cassoni P, Catapano F, Marrocco T, Deghenghi R, Ghigo E, Muccioli G, Papotti M. The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. Endocrinology. 2002 Feb 143;(2):484-91.
41. Kusunoki H, Haruma K, Hata J, Ishii M, Kamada T, Yamashita N, Honda K, Inoue K, Imamura H, Manabe N, Shiotani A, Tsunoda T. Efficacy of Rik- kunshito, a traditional Japanese medicine (Kampo), in treating functional dyspepsia. Intern Med. 2010 49;(20):2195-202.
42. Suzuki H, Inadomi JM, Hibi T. Japanese herbal medicine in functional gastrointestinal disorders. Neurogastroenterol Motil. 2009 Jul 21;(7):688-96.
43. Kawahara H, Okuyama H, Nose K, Nakai H, Yoneda A, Kubota A, Fukuzawa M. Physiological and clini- cal characteristics of gastroesophageal reflux after congenital diaphragmatic hernia repair. J Pediatr Surg. 2010 Dec 45;(12):2346-50.
44. Johnson DA, Levy BH, 3rd. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors. Expert Opin Pharmacother. 2010 Jun 11;(9):1541-8.
45. Miwa H, Koseki J, Oshima T, Kondo T, Tomita T, Watari J, Matsumoto T, Hattori T, Kubota K, Iizuka S. Rikkunshito, a traditional Japanese medi- cine, may relieve abdominal symptoms in rats with experimental esophagitis by improving the barrier function of epithelial cells in esophageal mucosa. J Gastroenterol. 2010 May 45;(5):478-87.
46. Matsumura T, Arai M, Yonemitsu Y, Maruoka D, Tanaka T, Suzuki T, Yoshikawa M, Imazeki F, Yokosuka O. The traditional Japanese medicine Rikkunshito increases the plasma level of ghrelin in humans and mice. J Gastroenterol. 2010 Mar 45;(3):300-7.
47. Yakabi K, Noguchi M, Ohno S, Ro S, Onouchi T, Ochiai M, Takabayashi H, Takayama K, Harada Y, Sadakane C, Hattori T. Urocortin 1 reduces food intake and ghrelin secretion via CRF2 receptors. Am J Physiol Endocrinol Metab. 2011 Jul 301;(1): E72-E82.
48. Yakabi K, Sadakane C, Noguchi M, Ohno S, Ro S, Chinen K, Aoyama T, Sakurada T, Takabayashi H, Hattori T. Reduced ghrelin secretion in the hypo- thalamus of rats due to cisplatin-induced anorexia. Endocrinology. 2010 Aug 151;(8):3773-82.
49. Yakabi K, Kurosawa S, Tamai M, Yuzurihara M, Nahata M, Ohno S, Ro S, Kato S, Aoyama T, Sakurada T, Takabayashi H, Hattori T. Rikkunshito and 5-HT2C receptor antagonist improve cisplatin- induced anorexia via hypothalamic ghrelin interaction. Regul Pept. 2010 Apr 9;161(1-3):97-105.
50. Takeda H, Muto S, Hattori T, Sadakane C, Tsuchiya K, Katsurada T, Ohkawara T, Oridate N, Asaka M. Rikkunshito ameliorates the aging-associated decrease in ghrelin receptor reactivity via phospho- diesterase III inhibition. Endocrinology. 2010 Jan 151;(1):244-252.